Injectable contraceptive use in women with intellectual disability: narrative review and service evaluation
Background Intellectual disability is defined as an IQ of 70 or below. Women with intellectual disability frequently experience menstrual distress leading to the use of hormonal medications such as depot medroxyprogesterone acetate (DMPA). Despite risks such as reduced bone mineral density (BMD) a...
Saved in:
| Main Authors: | Marianne Bergman, Alaa Martin |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Cambridge University Press
2025-09-01
|
| Series: | BJPsych Open |
| Subjects: | |
| Online Access: | https://www.cambridge.org/core/product/identifier/S2056472425007860/type/journal_article |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Injectable Contraceptive Use in Women With Intellectual Disability – A Narrative Review and Local Case Series
by: Marianne Bergman, et al.
Published: (2025-06-01) -
Examination of physical fitness parameters of trainable individuals with intellectual disability
by: Bilal Karakoç
Published: (2022-03-01) -
Physical and sports activities of students with intellectual disabilities
by: Golikova, Elena M.
Published: (2025-03-01) -
Changes in Canadian contraceptive choices: results of a national survey on hormonal contraceptive use
by: Allison J. Campbell, et al.
Published: (2025-03-01) -
Oral Contraception: Five important issues
by: D.R. Slabbert, et al.
Published: (2005-02-01)